#Japan #Osaka #Clinical Research #Patient Care #Linical

Celebrating Two Decades of Linical

In an admirable milestone, Linical commemorates its 20th anniversary, showcasing two decades of commitment to elevating patient health through high-quality, patient-focused research. Founded in 2005 in Japan, this organization has grown from a modest team driven by a bold vision to a global leader in clinical research, operating across more than 30 countries.

From the inception, Linical aimed to do more than just conduct clinical studies. The company has continuously strived to make a lasting difference in patients' lives. Over the years, Linical has expanded its service offerings significantly. Today, they cover extensive aspects such as complete clinical trial management, site selection and feasibility, regulatory support, biometrics, pharmacovigilance, and drug development strategies. Despite this growth, Linical's core mission remains unchanged: advancing science while prioritizing the safety and well-being of patients.

Kazuhiro Hatano, the President and CEO of Linical, stated, "What began as a small start-up with a handful of dedicated professionals in the pharmaceutical industry has evolved into a global force in clinical research. We have never lost sight of the fact that at the heart of every clinical study is a patient who hopes for a better future. That is what continues to drive us."

In its 20 years, Linical has supported hundreds of clinical trials across various therapeutic areas, including oncology, neurology, immunology, and rare diseases. By leveraging technology and data-driven processes, the company has achieved faster study start times, enhanced site performance, and improved study quality. Their significant investments in resources for decentralized clinical trials and digital tools have positioned Linical at the forefront of innovation, particularly at a time when flexibility and accessibility in research are paramount.

Hatano further emphasized, "In clinical research, it ultimately comes down to people. It involves the individuals participating in studies, the researchers treating them, and the sponsors developing new therapies. We pride ourselves on being a part of this ecosystem and contributing to turning scientific discoveries into real-world impacts."

Marking its 20th anniversary, Linical also looks towards the future. The advent of artificial intelligence is transforming the clinical research landscape. Through ongoing investments in global activities, advanced analytics, and patient-oriented technologies, Linical plans to enhance its capability to conduct efficient, high-quality clinical trials, expediting new therapies to market.

"We are proud of what we have achieved, but we are even more excited about what lies ahead," Hatano remarked. "Our work is far from over, and we remain dedicated to our mission of improving lives through research."

For more information, Linical provides specialized clinical research services aimed at assisting biopharmaceutical companies in bringing innovative therapies to patients across APAC, Europe, and North America. With a focus on quality, technology, and patient well-being, Linical tailors solutions for clinical trials in all phases across numerous therapeutic areas.